Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 September 2021 | Story Jóhann Thormählen | Photo Charl Devenish
The University of the Free State celebrated the achievements of the Paralympic athlete, Louzanne Coetzee. She won silver and bronze medals at the Paralympic Games in Tokyo.

It is great to be back with her University of the Free State (UFS) family, and Louzanne Coetzee would not have been able to reach her dreams without her Kovsie support.

The Paralympic star thanked the UFS for the role it played in her career and said it was a privilege to represent the UFS and South Africa.

She returned from the Paralympic Games in Tokyo with silver (1 500 m; T11) and bronze (marathon; T12) medals and was welcomed back at a special UFS celebration on 13 September 2021.

The 28-year-old, her guides – Estean Badenhorst and Claus Kempen – and a small group of UFS dignitaries celebrated her achievements.

The Residence Head of Akasia Residence at the UFS not only brought home two medals, but also set a new 1 500 m African record (T11; 4:40.96) and a new world marathon record (T11; 3:11:13) in her class.

Support from home

Coetzee is a UFS alumna who started running while being a Kovsie student.

“Thank you so much for the welcome back,” she said.

“It is great to come back home to my UFS family. Especially after three weeks in another country.”

She said the support messages from the likes of Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, meant a lot while she was in Tokyo.

“I, Claus, and Estean would not have been able to do this without the support of the UFS and Oom DB (Prinsloo; Director of KovsieSport).”

Representing the UFS and the continent

She made special mention of Badenhorst and Kempen, who also run for the Kovsie Athletics Club. “I really feel we function well as a team, and I think the results have been fruitful.”

Prof Petersen praised and thanked them, also for representing the UFS, South Africa, and the continent in such a superb manner.

It is great to come back home to my UFS family. Especially after three weeks in another country. – Louzanne Coetzee

 

“You really made us proud as the University of the Free State family, and I know that you will continue with great performances in the future,” he said.

Prinsloo said KovsieSport is immensely proud of the trio and for being UFS ambassadors.

“Thank you very much. We are looking forward to the next couple of years.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept